Detailed View
SRPT - Sarepta Therapeutics, Inc.
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
1,583,643,392
Adj EBIT (TTM)
-40,962,000
Enterprise Value
930,404,392
Last Price
15
Earnings Yield
-4.40%
Return on Capital
-1.53%
Capital
2,679,770,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 730,803,000 | 358,433,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 442,934,000 | -411,583,000 |
| 2025-09-30 | 10-Q | 2025 | 399,356,000 | -103,389,000 |
| 2025-06-30 | 10-Q | 2025 | 611,091,000 | 115,577,000 |
| 2025-03-31 | 10-Q | 2025 | 744,856,000 | -300,386,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 658,412,000 | 161,681,000 |
| 2024-09-30 | 10-Q | 2024 | 467,172,000 | 22,196,000 |
| 2024-06-30 | 10-Q | 2024 | 362,931,000 | -701,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.